Brain training may boost hearing and thinking in older cochlear implant users

NCT ID NCT05176561

ENROLLING_BY_INVITATION Symptom relief Sponsor: Gallaudet University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an 8-week auditory-cognitive training program can improve speech recognition and cognitive function in older adults (60+) who have had a cochlear implant for 3 months to 3 years. Participants will do computer-based listening and thinking exercises at home plus weekly virtual meetings with a clinician. The goal is to see if this training can help them understand speech better and improve their quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Auditory-cognitive training program
What this could lead to: If it works, this could point toward a simple, non-drug way to help older cochlear implant users hear better and think more clearly.
What could go wrong: This is a small, early-stage study with only 30 participants. The training may not lead to meaningful improvements, and results may not apply to all cochlear implant users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEAFNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Deafness hearing loss disorder postlingual non-syndromic genetic hearing loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEAFNESS HEARING LOSS

Contacts and locations

Locations

Center for Hearing and Communication

New York, New York, 10004, United States
Gallaudet University

Washington D.C., District of Columbia, 20002, United States
Vanderbilt University

Nashville, Tennessee, 37203-8820, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.